DR REDDYS LABORATORIES
Back to Cashflow Statement
|
DR REDDYS LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹1,891 Cr | ₹-376 Cr | ₹-2,686 Cr | ₹-242 Cr | ₹-30 Cr |
What is the latest Cash Flow from Financing Activities ratio of DR REDDYS LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹1,891 Cr |
| Mar2024 | ₹-376 Cr |
| Mar2023 | ₹-2,686 Cr |
| Mar2022 | ₹-242 Cr |
| Mar2021 | ₹-30 Cr |
How is Cash Flow from Financing Activities of DR REDDYS LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹1,891 Cr | Positive | |
| Mar2024 | ₹-376 Cr | Negative | |
| Mar2023 | ₹-2,686 Cr | Negative | |
| Mar2022 | ₹-242 Cr | Negative | |
| Mar2021 | ₹-30 Cr | - | |
Compare Cash Flow from Financing Activities of peers of DR REDDYS LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| DR REDDYS LABORATORIES | ₹105,689.6 Cr | 0.9% | 4.8% | -3.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹416,884.0 Cr | -0.7% | -0.5% | -3.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹172,442.0 Cr | 2.9% | 1.8% | 11.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹129,770.0 Cr | 1.5% | 3.4% | 12.4% | Stock Analytics | |
| CIPLA | ₹120,871.0 Cr | 0.2% | -0.2% | 0.4% | Stock Analytics | |
| MANKIND PHARMA | ₹90,579.8 Cr | 5.7% | 0.5% | -24.3% | Stock Analytics | |
DR REDDYS LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| DR REDDYS LABORATORIES | 0.9% |
4.8% |
-3.2% |
| SENSEX | 1% |
0.6% |
7.8% |
You may also like the below Video Courses